Tarsons Products Ltd

Tarsons Products Ltd, a micro-cap player in the Healthcare Services sector, has witnessed a notable shift in its valuation parameters, raising questions about its price attractiveness amid a strong recent price rally. Despite a 15.64% surge in a single day and a year-to-date positive return, the company’s elevated price-to-earnings (P/E) and price-to-book value (P/BV) ratios now position it as an expensive stock relative to its historical and peer averages, prompting a downgrade to a Strong Sell rating.

Tarsons Products Ltd, a micro-cap player in the Healthcare Services sector, has exhibited a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals. Despite a modest daily price increase of 1.66% to ₹205.30 on 15 Jun 2026, the stock remains under pressure with a strong sell rating and deteriorating long-term returns compared to the broader Sensex.

Tarsons Products Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 25 May 2026. However, the analysis and financial metrics presented here reflect the stock’s current position as of 14 June 2026, providing investors with the latest insights into the company’s performance and outlook.

Tarsons Products Ltd, a micro-cap player in the Healthcare Services sector, has experienced a notable shift in its technical momentum, signalling increased bearishness. The stock’s recent price action, combined with mixed technical indicator readings, paints a challenging picture for investors amid a broader market context that has seen the company underperform the Sensex over multiple time frames.

Tarsons Products Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 25 May 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 03 June 2026, providing investors with the latest insights into the company’s performance and outlook.

Tarsons Products Ltd, a micro-cap player in the Healthcare Services sector, has seen its quality grade downgraded from average to below average as of 25 May 2026. This shift reflects deteriorating business fundamentals, including weakening profitability metrics, stretched debt levels, and inconsistent growth patterns, which have raised concerns among investors and analysts alike.

Tarsons Products Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 08 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Tarsons Products Ltd., a micro-cap healthcare services company with a market capitalisation of ₹1,125 crores, reported a challenging fourth quarter for FY26, with net profit declining 59.02% year-on-year to ₹4.18 crores despite revenue growth of 7.31%. The stock, trading at ₹218.25 as of May 22, 2026, has witnessed significant volatility, down 42.87% over the past year, substantially underperforming both the benchmark Sensex and its healthcare services sector peers.

Tarsons Products Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 08 Apr 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 12 May 2026, providing investors with an up-to-date view of its performance and outlook.

Tarsons Products Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 08 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 May 2026, providing investors with the latest insights into its performance and outlook.

Tarsons Products Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 8 April 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the stock's current position as of 20 April 2026, providing investors with the latest comprehensive analysis.

Tarsons Products Ltd, a micro-cap player in the Healthcare Services sector, has experienced a subtle shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook. Despite a 3.25% gain in the latest session, the stock’s technical indicators present a complex picture, reflecting mixed signals that investors should carefully analyse before making decisions.

Tarsons Products Ltd, a micro-cap player in the healthcare services sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish to a bearish trend. Recent technical indicators including MACD, RSI, and moving averages reveal a complex picture of weakening price momentum, signalling caution for investors amid ongoing market volatility.

Tarsons Products Ltd, a micro-cap player in the healthcare services sector, has seen its investment rating upgraded from Strong Sell to Sell as of 8 April 2026. This change reflects a nuanced improvement in technical indicators and valuation metrics, despite ongoing challenges in financial performance and long-term growth prospects.

Tarsons Products Ltd, a micro-cap player in the Healthcare Services sector, has experienced a notable shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook. Despite a recent day gain of 2.28%, the stock’s broader technical indicators present a complex picture, reflecting mixed signals across weekly and monthly timeframes. This analysis delves into the evolving technical landscape, juxtaposing price action with key momentum indicators such as MACD, RSI, moving averages, and volume trends to provide investors with a comprehensive view of the stock’s current trajectory.

Tarsons Products Ltd, a micro-cap player in the healthcare services sector, has seen its valuation parameters shift from attractive to fair, reflecting a nuanced change in investor sentiment amid a challenging market backdrop. Despite a modest day gain of 2.28%, the company’s price-to-earnings (P/E) ratio now stands at a lofty 48.95, signalling a re-rating that warrants close scrutiny by investors seeking value in the healthcare space.